Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
Use this TCRX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the TCRX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the TCRX SEC filings page. Lician reads the product cache first so this HTML stays unique to Tscan Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full TCRX income, balance, and cash tables.